GLC Medical (GLCM), a subsidiary of Graphene Leaders Canada (GLC), recently announced completion of development of the GLCM SARS-CoV-2 Insta-Test, delivering results in under 15 seconds, offering fast and easy to use solution to screen for COVID-19.
The Company stated that it sees potential for this new graphene-based biosensor to enable the world to regain a sense of freedom and bring “normal” back into its future.
Read More | Graphene-Info
Graphene applications, Graphene Sensors, Medicine
More Graphene news
STEK Automotive launches graphene-enhanced window films
Graphene-based electrochemical sensor can detect COVID-19 in less than five minutes
GAC to test its “super-fast-charging battery” in production vehicles
Graphmatech uses its graphene technology to push forward copper additive manufacturing
Researchers design an accurate, high-speed, portable bifunctional electrical detector for COVID-19
Fixing ‘food miles’: how graphene-enhanced farming can cut costs and emissions
Covid-19 and graphene, a current overview
GAC Group announces that its Aion V, sporting a graphene battery, will start production in September 2021
MIT research honored with Physics World “Breakthrough of the Year” awards
Creating new opportunities from nanoscale materials
AMD announces first contract under the Defense Science and Technology Laboratory (DSTL)
Talga reports positive results from marine real-world testing of its graphene-based coatings
Exotic “second sound” phenomenon observed in pencil lead
Researchers map tiny twists in “magic-angle” graphene
Physicists create tunable superconductivity in twisted graphene “nanosandwich”
The best of 2020 – top graphene stories
Beyond chip-and-PIN: graphene’s quick, hygienic solution to restaurant payment
Directa Plus receives further reassurance that its GNPs are not absorbed through human skin
How to mass produce cell-sized robots
Graphene Engineering Innovation Centre announces new Tier-One partnership